Meta-analysis in clinical research

Abstract

Get full access to this article

View all access options for this article.

References

Whitehead A. Meta-analysis of controlled clinical trials, Chichester: Wiley.

Senn

. Statistical issues in drug development, 2nd ed. Hoboken: Wiley, 2007.

Lane PW. Meta-analysis of incidence of rare events. Stat Meth Med Res 2013; 22(2): 117--132.

Amit

Heiberger

Lane

. Graphical approaches to the analysis of safety data from clinical trials. Pharmaceut Stat 2008; 7: 20–35.

Julious SA. Efficacy and suicidal risk for antidepressants in paediatric and adolescent patients. Stat Meth Med Res 2013; 22(2): 190--218.

Julious

Whitehead

. Investigating the assumption of homogeneity of treatment effects in clinical studies with application to meta-analysis. Pharmaceut Stat 2012; 11(1): 49–56.

Salanti

Higgins

Ades

. Evaluation of networks of randomized trials. Stat Meth Med Res 2008; 17(3): 279–301.

Senn S, Gavini F, Magrez D, et al. Issues in performing a network meta-analysis. Stat Meth Med Res 2013; 22(2): 169--189.

Julious

Wang

. Issues with indirect comparisons in clinical trials particularly with respect to non-inferiority trials. Drug Inform J 2008; 42(6): 625–633.

10.

Julious

. The ABC of non-inferiority margin setting from indirect comparisons. Pharmaceut Stat 2011; 10(5): 448–453.

11.

Witte

Schmidli

O'Hagan

. Designing a non-inferiority study in kidney transplantation: a case study. Pharmaceut Stat 2011; 10: 427–432.

12.

Julious

Owen

. A comparison of methods for sample size estimation for non-inferiority studies with binary outcomes. Stat Meth Med Res 2011; 20(6): 595–612.

13.

Schmidli H, Wandel S and Neuenschwander B. The network meta-analytic-predictive approach to non-inferiority trials. Stat Meth Med Res 2013; 22(2): 219--240.

14.

Ishak

Platt

Joseph

. Impact of approximating or ignoring within-study covariances in multivariate meta-analyses. Stat Med 2008; 27: 670–686.

15.

Mavridis D and Salanti G. A practical introduction to multivariate meta-analysis. Stat Meth Med Res 2013; 22(2): 133--158.

16.

Stallard

Todd

. Seamless phase II/III designs. Stat Meth Med Res 2011; 20(6): 623–634.

17.

Whitehead

. Group sequential trials revisited: simple implementation using SAS. Stat Meth Med Res 2011; 20(6): 635–656.

18.

Bassler

Briel

Montori

. Stopping randomized trials early for benefit and estimation of treatment effects: systematic review and meta-regression analysis. JAMA 2010; 303: 1180–1187.

19.

Mueller

Montori

Bassler

. Ethical issues in stopping randomized trials early because of apparent benefit. Ann Intern Med 2007; 146: 878–881.

20.

Bassler D, Montori VM, Briel M, et al. Reflections on meta-analyses involving trials stopped early for benefit: is there a problem and if so, what is it? Stat Meth Med Res 2013; 22(2): 159--168.